Prospective evaluation of indirect costs due to acute rotavirus gastroenteritis in Spain: The ROTACOST study

BMC Pediatrics

Volumn 11, Issue , 2011, Pages

  Bouzón Alejandro, Marta ^a,c   Redondo Collazo, Lorenzo ^a,b,c   Sánchez Lastres, Juan M ^c,d   Martinón Torres, Nazareth ^a,b,c   Martinón Sánchez, José M ^a,b,c   Martinón Torres, Federico ^a,b,c  

^a Instituto de Salud Carlos III   (Spain)

^b Instituto de Investigación   (Spain)

^c Red Gallega de Investigación Pediátrica   (Spain)

^d Centro de Salud de Chapela   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ROTAVIRUS VACCINE;

ABSENTEEISM; ARTICLE; CHILD; COST OF ILLNESS; EVALUATION; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MONEY; OBSERVATIONAL STUDY; PRESCHOOL CHILD; PROSPECTIVE STUDY; ROTAVIRUS INFECTION; SPAIN; VIRAL GASTROENTERITIS;

EID: 80052860268     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-11-81     Document Type: Article

References (27)

1. Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and death caused by rotavirus disease. Emerg Infect Dis 2003, 12:304-306.
2. Cunliffe NA, Kilgore PE, Bresee JS, Steele AD, Luo N, Hart C. Epidemiology of rotavirus in Africa: review to assess the need for rotavirus immunization. Bull World Health Organ 1998, 76:525-537. 2305791, 9868844.
3. Bern C, Martines J, de Zoysa I, Glass RI. The magnitude of the global problem of diarrhoeal disease: a ten year update. Bull World Health Organ 1992, 70:705-714. 2393403, 1486666.
4. De Zoysa I, Feachen RG. Intervention for the control of diarrhoeal disease among young children. Bull World Health Organ 1985, 63:569-583. 2536413, 3876173.
5. Kosek M, Bern C, Guerrant RL. The global burden of diarrhoeal, as estimated from studies published between 1992 and 2000. Bull World Health Organ 2003, 81:197-204. 2572419, 12764516.
6. Giménez Sánchez F, Martinón Torres F, Bernaola Iturbe E, Baca Cots M, de Juan Martín F, Díez Delgado J, Garcés Sánchez M, Gómez Campderá JA, Picazo J, Pineda Solas V. The role of the rotavirus vaccine in childhood vaccination schedules. An Pediatr (Barc) 2006, 64:573-577.
7. Soriano-Gabarró M, Mrukowicz J, Vesikari T, Verstraeten T. Burden of rotavirus disease in European Union countries. Pediatr Infect Dis J 2006, 25:S7-S11. 10.1097/01.inf.0000197622.98559.01, 16397431.
8. Glass RI. The promise of new rotavirus vaccines. N Engl J Med 2006, 354:75-77. 10.1056/NEJMe058285, 16394305.
9. Lepage P. Rotavirus infection in Europe: time for effective prevention?. Pediatr Infect Dis J 2006, 25(1 Suppl):S5-S6.
10. Mrukowicz JZ, Krobicka B, Duplaga M, Kowalska-Duplaga K, Domañski J, Szajewska H, Kantecki M, Iwañczak F, Pytrus T. Epidemiology and impact of rotavirus diarrhoea in Poland. Acta Paediatr 1999, 88:53-60.
11. Vesikari T, Rautanen T, Von Bonsdorff CH. Rotavirus gastroenteritis in Finland: burden of disease and epidemiological features. Acta Paediatr Suppl 1999, 426:24-30.
12. Rheingans RD, Heylen H, Giaqinto C. Economic of rotavirus gastroenteritis and vaccination in Europe. Pediatr Infect Dis J 2006, 25:S48-S55. 10.1097/01.inf.0000197566.47750.3d, 16397429.
13. Fruhwirth M, Berger K, Ehlken B, Moll-Schuler I, Brosl S, Mutz I. Economic impact of community- and nosocomially acquired rotavirus gastroenteritis in Austria. Pediatr Infect Dis J 2001, 20:184-188. 10.1097/00006454-200102000-00013, 11224839.
14. Takala AK, Koskenniemi E, Joensuu J, Makela M, Vesikari T. Economic evaluation of rotavirus vaccinations in Finland: randomized, double-blind, placebo-controlled trial of tetravalent rhesus rotavirus vaccine. Clin Infect Dis 1998, 27(2):272-282. 10.1086/514650, 9709876.
15. Floret D, Lina B, Pinchinat S, Billaud G, Aït-Belghiti F, Largeron N, Bellemin B, Trang CN, Fau C, Gaspard C, Mamoux V, Marcelon L. Epidemiology and burden of rotavirus diarrhea in day care centers in Lyon, France. Eur J Pediatr 2006, 165(12):905-6. 10.1007/s00431-006-0187-z, 16900310.
16. Gil A, Carrasco P, Jiménez R, San-Martín M, Oyagüez I, González A. Burden of hospitalizations attributable to rotavirus infection in children in Spain, period 1999-2000. Vaccine 2004, 22:2221-2225. 10.1016/j.vaccine.2003.11.037, 15149780.
17. Gil de Miguel A, Carrasco Garrido P, Esteban Hernández J, San-Martín Rodríguez M, González López A. Burden of hospitalizations attributable to rotavirus infection in children in the Autonomous Region of Madrid, Spain, period 1999-2000. An Pediatr (Barc) 2006, 64:530-535.
18. Martinón-Torres F, Bouzón-Alejandro M, López-Sousa M, Redondo-Collazo L, Almeida-Agudín S, Astorgano-Fernández C, Martinón-Sánchez J. An estimation of indirect costs caused by acute rotavirus gastroenteritis in a Galician area, Spain. Eur J Pediatr 2008, 167:337-339. 10.1007/s00431-007-0466-3, 17364172.
19. Lopez-Sousa M, Bouzón-Alejandro M, Martinón-Torres F. Rotavirus and its indirect costs. An Pediatr (Barc) 2008, 69(1):89-90.
20. Giaquinto C, Van Damme P, Huet F, Gotheforrs L, Van der Wielen M, . on behalf of the REVEAL study Group Costs of Community-Acquired Pediatric Rotavirus Gastroenteritis in 7 European Countries: The REVEAL Study. J Infect Dis 2007, 195:S36-S44. 10.1086/516716, 17539193, on behalf of the REVEAL study Group.
21. Lee BP, Azimi PH, Staat MA, Louie L, Parada E, Berke T, Ward RL, Bernstein DI, Matson DO. Nonmedical costs associated with rotavirus disease requiring hospitalization. Pediatr Infect Dis J 2005, 24:984-988. 10.1097/01.inf.0000183754.29707.cd, 16282934.
22. Griffiths RI, Anderson GF, Powe NR, Oliveras E, Herbert RJ, Grant CC, Davidson BL. Economic impact of immunization against rotavirus gastroenteritis. Evidence from a clinical trial. Arch Pediatr Adolesc Med 1995, 149:407-414.
23. Liddle JL, Burgess MA, Gilbert GL, Hanson RM, McIntyre PB, Bishop RF, Ferson MJ. Rotavirus gastroenteritis: impact on young children, their families and the health care system. Med J Aust 1997, 167:304-307.
24. Roberts JA, Cumberland P, Sockett PN, Wheeler J, Rodrigues LC, Sethi D, Roderick PJ, . Infectious Intestinal Disease Study Executive The study of infectious intestinal disease in England: socio-economic impact. Epidemiol Infect 2003, 130:1-11. 10.1017/S0950268802007690, 2869933, 12613740, Infectious Intestinal Disease Study Executive.
25. Tucker AW, Haddix AC, Bresee JS, Holman RC, Parashar UD, Glass RI. Cost-effectiveness analysis of a rotavirus immunization program for the United States. JAMA 1998, 279:1371-1376. 10.1001/jama.279.17.1371, 9582045.
26. Díez-Domingo J, Martín IO, SAnz AB, López AG, Martínez CC, Boronat CP. Rotavirus gastroenteritis among children under five years of age in Valencia, Spain. Pediatr Infect Ds J 2006, 25:455-457.
27. Diez-Domingo J, Lara Suriñach N, Malé Alclade N, Betegón L, Largeron N, Trichard M. Burden of paediatric rotavirus gastroenteritis (RVGE) and potential benefits of a universal rotavirus vaccination programme with a pentavalent vaccine in Spain. BMC Public Health 2010, 10:469. 10.1186/1471-2458-10-469, 2927540, 20698958.